Corporate
Description
  • Value proposition

    Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.

    Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il

    Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
    http://www.tevapharm.com/contact_us/

    generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology

Entity interactions BETA
Entity TypeTweets Articles
Life Science Leader Life Science Leader
Book and Periodical Publishing
Other

9 Dec 2024


ALSTROM SYNDROME UK ALSTROM SYNDROME UK
healthtech, Hospitals and Health Care
Other

30 Sep 2024


Domain Therapeutics Domain Therapeutics
biotech, deeptech, Pharmaceutical Manufacturing
Other

30 Nov 2024


e-fellows.net e-fellows.net
hrtech, Human Resources Services
Other

23 Nov 2024


Fundación Artepaliativo Fundación Artepaliativo
it services, Wellness and Fitness Services
Other

29 Nov 2024


AC Immune AC Immune
biotech, deeptech, healthtech, Biotechnology Research
Other

28 Nov 2024


Venture Valuation AG Venture Valuation AG
Financial Services
Other

30 Sep 2024


11TEN Innovation Partners 11TEN Innovation Partners
Business Consulting and Services
Other

30 Sep 2024


genOway genOway
biotech, deeptech, Biotechnology Research
Other

21 Nov 2024


Soleterre Soleterre
healthtech, Civic and Social Organizations
Other

30 Sep 2024


Radars
Loading...